众生药业：公司始终坚持合规经营

Core Viewpoint - The company emphasizes its commitment to compliance and proper disclosure, asserting that it adheres strictly to information disclosure rules and has no undisclosed matters that should have been disclosed [1] Group 1 - The company responds to investor inquiries on November 21, indicating its ongoing commitment to compliant operations [1] - The company states that it will fulfill its information disclosure responsibilities in accordance with relevant standards [1] - The company assures that it will promptly disclose any matters that meet the relevant disclosure criteria [1]